Management of AIDS-related Kaposi's sarcoma: Advances in target discovery and treatment

Expert Review of Anticancer Therapy

Volumn 2, Issue 2, 2002, Pages 193-200

  Dezube, Bruce J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Alitretinoin; Angiogenesis inhibitors; COL 3; DaunoXome; Doxil; Fumagillin; HHV 8; Kaposis's sarcoma; Metastat; Paclitaxel; Panretin; Thalidomide

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; ALITRETINOIN; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTHRACYCLINE DERIVATIVE; ANTIRETROVIRUS AGENT; BLEOMYCIN; CYTOCHROME P450; DAUNORUBICIN; DEXAMETHASONE; DIDANOSINE; DIPHENHYDRAMINE; DOXORUBICIN; FUMAGILLIN; INDINAVIR; INTERLEUKIN 12; LIPOSOME; MATRIX METALLOPROTEINASE INHIBITOR; NEVIRAPINE; PACLITAXEL; PROTEINASE INHIBITOR; RANITIDINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; THALIDOMIDE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALOPECIA; ANGIOGENESIS; CANCER SIZE; CARDIOTOXICITY; CELL DIFFERENTIATION; CHILL; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG INTERACTION; DRUG METABOLISM; DRUG TARGETING; FEVER; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIVER TOXICITY; NEUROTOXICITY; NEUTROPENIA; PATHOGENESIS; PHARMACOKINETICS; PLASMA HALF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SKIN ALLERGY; VIRUS LOAD;

EID: 0036081070     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.2.2.193     Document Type: Review

References (49)

1. Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk
2. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
3. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
4. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
5. Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: A missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma
6. Acquired immunodeficiency syndrome-related Kaposi's sarcoma: Clinical features, staging and treatment
7. Psychosocial considerations in the therapy of epidemic Kaposi's sarcoma
8. Treating Kaposi's lesions in the HIV-infected patient
9. Gastrointestinal malignancy in patients with AIDS
10. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: A prospective evaluation using an endoscopic method of disease quantification
11. Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases
12. The epidemiologic, pathologic and clinical features of AIDS-associated pulmonary Kaposi's sarcoma
13. Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy
14. Pulmonary Kaposi's sarcoma: Clinical findings and results of therapy
15. Pulmonary manifestations of Kaposi's sarcoma
16. Endobronchial lesions in HIV-infected individuals
17. AIDS-related Kaposi sarcoma of the lung: Radiographic findings and staging system with bronchoscopic correlation
18. Cat scratch disease, bacillary angiomatosis and other infections due to Rochalimaea
19. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS)
20. The appearance of Kaposi sarcoma during corticosteroid therapy
21. Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response and staging criteria
22. AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification
23. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus Type 1-and human herpesvirus 8-coinfected patients
24. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor
25. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir
26. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy
27. Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy
28. Highly active antiretroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
29. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study. Swiss HIV Cohort Study
30. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel
31. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection
32. The role of radiation therapy in the management of HIV-related Kaposi's sarcoma
33. Palliative treatment of epidemic Kaposi sarcoma of the feet
34. Prospective randomized trial of two dose levels of interferon-α with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: A Canadian HIV Clinical Trials Network study
35. Randomized, openlabel, Phase II AIDS Clinical Trials Group study of two doses of interferon-α-2b with didanosine in patients with AIDS-associated Kaposi's sarcoma: Efficacy of daily low-dose interferon
36. Chemotherapy of AIDS-related Kaposi's sarcoma
37. Randomized Phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin and vincristine in AIDS-related Kaposi's sarcoma
38. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized Phase III clinical trial
39. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
40. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy
41. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
42. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
43. Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma
44. Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma-drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: A case report study
45. Fumagillin analog in the treatment of Kaposi's sarcoma: A Phase I AIDS Clinical Trial Group study
46. Activity of thalidomide in AIDS-related Kaposi's sarcoma
47. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: A Phase I AIDS malignancy consortium study
48. Administration of interleukin-12 to patients with AIDS-associated Kaposi's sarcoma: Preliminary results of a pilot study
49. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma